Elisabet Londos

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF ALZHEIMERS DISEASE. 2022;89(4):1403-1412
A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born?
Nyholm E; Torkpoor R; Frölich K; Londos E; Cicognola C
Article: JOURNAL OF ALZHEIMERS DISEASE. 2022;89(3):865-876
Diagnostic Accuracy of the Swedish Version of the Rowland Universal Dementia Assessment Scale (RUDAS-S) for Multicultural Cognitive Screening in Swedish Memory Clinics.
Torkpoor R; Frolich K; Nielsen TR; Londos E
Article: JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES. 2022;60(5):29-36
Choral Singing Enriches Everyday Life for People With Mild to Moderate Dementia and Their Family Caregivers.
Fälth N; Brorsson A; Londos E
Article: JOURNAL OF CROSS-CULTURAL GERONTOLOGY. 2022;37(1):45-67
"I Know Hyena. Do you Know Hyena?" Challenges in Interpreter-Mediated Dementia Assessment, Focusing on the Role of the Interpreter.
Torkpoor R; Fioretos I; Essén B; Londos E
Article: EUROPEAN RADIOLOGY. 2022;32(2):1127-1134
Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience
Hakansson C; Tamaddon A; Andersson H; Torisson G; Martensson G; Truong M; Annertz M; Londos E; Bjorkman-Burtscher IM; Hansson O; van Westen D
Article: EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY. 2021;3:100054
Medications causing potential cognitive impairment are common in nursing home dementia units - A cross-sectional study.
Kristensson JH; Zahirovic I; Londos E; Modig S
Article: MOVEMENT DISORDERS. 2021;36(3):767-771
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.
Hall S; Janelidze S; Londos E; Leuzy A; Stomrud E; Dage JL; Hansson O
Article: NATURE GENETICS. 2021;53(3):294-303
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.
Chia R; Sabir MS; Bandres-Ciga S; Saez-Atienzar S; Reynolds RH; Gustavsson E; Walton RL; Ahmed S; Viollet C; Ding J; Makarious MB; Diez-Fairen M; Portley MK; Shah Z; Abramzon Y; Hernandez DG; Blauwendraat C; Stone DJ; Eicher J; Parkkinen L; Ansorge O; Clark L; Honig LS; Marder K; Lemstra A; St George-Hyslop P; Londos E; Morgan K; Lashley T; Warner TT; Jaunmuktane Z; Galasko D; Santana I; Tienari PJ; Myllykangas L; Oinas M; Cairns NJ; Morris JC; Halliday GM; Van Deerlin VM; Trojanowski JQ; Grassano M; Calvo A; Mora G; Canosa A; Floris G; Bohannan RC; Brett F; Gan-Or Z; Geiger JT; Moore A; May P; Krüger R; Goldstein DS; Lopez G; Tayebi N; Sidransky E; American Genome Center; Norcliffe-Kaufmann L; Palma J-A; Kaufmann H; Shakkottai VG; Perkins M; Newell KL; Gasser T; Schulte C; Landi F; Salvi E; Cusi D; Masliah E; Kim RC; Caraway CA; Monuki ES; Brunetti M; Dawson TM; Rosenthal LS; Albert MS; Pletnikova O; Troncoso JC; Flanagan ME; Mao Q; Bigio EH; Rodríguez-Rodríguez E; Infante J; Lage C; González-Aramburu I; Sanchez-Juan P; Ghetti B; Keith J; Black SE; Masellis M; Rogaeva E; Duyckaerts C; Brice A; Lesage S; Xiromerisiou G; Barrett MJ; Tilley BS; Gentleman S; Logroscino G; Serrano GE; Beach TG; McKeith IG; Thomas AJ; Attems J; Morris CM; Palmer L; Love S; Troakes C; Al-Sarraj S; Hodges AK; Aarsland D; Klein G; Kaiser SM; Woltjer R; Pastor P; Bekris LM; Leverenz JB; Besser LM; Kuzma A; Renton AE; Goate A; Bennett DA; Scherzer CR; Morris HR; Ferrari R; Albani D; Pickering-Brown S; Faber K; Kukull WA; Morenas-Rodriguez E; Lleó A; Fortea J; Alcolea D; Clarimon J; Nalls MA; Ferrucci L; Resnick SM; Tanaka T; Foroud TM; Graff-Radford NR; Wszolek ZK; Ferman T; Boeve BF; Hardy JA; Topol EJ; Torkamani A; Singleton AB; Ryten M; Dickson DW; Chiò A; Ross OA; Gibbs JR; Dalgard CL; Traynor BJ; Scholz SW
Article: EUROPEAN RADIOLOGY. 2021;31(2):666-673
Reporting frequency of radiology findings increases after introducing visual rating scales in the primary care diagnostic work up of subjective and mild cognitive impairment.
Håkansson C; Torisson G; Londos E; Hansson O; Björkman-Burtscher IM; van Westen D
Article: NEUROLOGY. 2020;95(24):e3257-e3268
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
Ferreira D; Przybelski SA; Lesnick TG; Lemstra AW; Londos E; Blanc F; Nedelska Z; Schwarz CG; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Savica R; Ferman TJ; Graff-Radford NR; Lowe VJ; Jack CR; Petersen RC; Mollenhauer B; Garcia-Ptacek S; Abdelnour C; Hort J; Bonanni L; Oppedal K; Kramberger MG; Boeve BF; Aarsland D; Westman E; Kantarci K
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2020;8(1):5
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.
Orme T; Hernandez D; Ross OA; Kun-Rodrigues C; Darwent L; Shepherd CE; Parkkinen L; Ansorge O; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday G; Stone DJ; Dickson DW; Hardy J; Singleton A; Guerreiro R; Bras J
Article: NEUROBIOLOGY OF DISEASE. 2019;127:492-501
Heritability and genetic variance of dementia with Lewy bodies.
Guerreiro R; Escott-Price V; Hernandez DG; Kun-Rodrigues C; Ross OA; Orme T; Neto JL; Carmona S; Dehghani N; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; International Parkinson's Disease Genomics Consort; Stone DJ; Bras J
Article: BMJ OPEN. 2019;9(5):e028010
Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes: a 6-year follow-up study.
Zahirovic I; Torisson G; Wattmo C; Londos E
Article: SCIENTIFIC REPORTS. 2019;9(1):7013
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
Rongve A; Witoelar A; Ruiz A; Athanasiu L; Abdelnour C; Clarimon J; Heilmann-Heimbach S; Hernandez I; Moreno-Grau S; de Rojas I; Morenas-Rodriguez E; Fladby T; Sando SB; Brathen G; Blanc F; Bousiges O; Lemstra AW; van Steenoven I; Londos E; Almdahl IS; Palhaugen L; Eriksen JA; Djurovic S; Stordal E; Saltvedt I; Ulstein ID; Bettella F; Desikan RS; Idland A-V; Toft M; Pihlstrom L; Snaedal J; Tarraga L; Boada M; Lleo A; Stefansson H; Stefansson K; Ramirez A; Aarsland D; Andreassen OA
Article: NEURORADIOLOGY. 2019;61(4):397-404
Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline.
Håkansson C; Torisson G; Londos E; Hansson O; van Westen D
Article: BMJ CASE REPORTS. 2019;12(3):e228177
Extreme sleep pattern in Lewy body dementia: a hypothalamic matter?
Londos E; Hansson O; Rosén I; Englund E
Article: NEUROBIOLOGY OF AGING. 2019;75:223.e1-223.e10
A comprehensive screening of copy number variability in dementia with Lewy bodies.
Kun-Rodrigues C; Orme T; Carmona S; Hernandez DG; Ross OA; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Guerreiro R; Bras J
Article: BMJ OPEN. 2019;9(1):e024983
Living with dementia with Lewy bodies: an interpretative phenomenological analysis.
Larsson V; Holmbom-Larsen A; Torisson G; Strandberg EL; Londos E
Article: CURRENT ALZHEIMER RESEARCH. 2018;15(10):905-916
Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
Wattmo C; Londos E; Minthon L
Article: SCIENTIFIC REPORTS. 2018;8(1):4717
¹⁸F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies
Smith R; Scholl M; Londos E; Ohlsson T; Hansson O
Article: BMC GERIATRICS. 2018;18(1):50
Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden.
Zahirovic I; Torisson G; Wattmo C; Londos E
Article: PLOS ONE. 2018;13(8):e0202044
Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia.
Larsson V; Torisson G; Londos E
Article: LANCET NEUROLOGY. 2018;17(1):64-74
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.
Guerreiro R; Ross OA; Kun-Rodrigues C; Hernandez DG; Orme T; Eicher JD; Shepherd CE; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Bras J
Article: BMJ OPEN. 2017;7(5):e014464
Importance and added value of functional impairment to predict mortality: a cohort study in Swedish medical inpatients.
Torisson G; Stavenow L; Minthon L; Londos E
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;57(3):787-795
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
Kramberger MG; Auestad B; Garcia-Ptacek S; Abdelnour C; Olmo JG; Walker Z; Lemstra AW; Londos E; Blanc F; Bonanni L; McKeith I; Winblad B; de Jong FJ; Nobili F; Stefanova E; Petrova M; Falup-Pecurariu C; Rektorova I; Bostantjopoulou S; Biundo R; Weintraub D; Aarsland D
Article: NEUROBIOLOGY OF AGING. 2017;49:214.e13-214.e15
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.
Kun-Rodrigues C; Ross OA; Orme T; Shepherd C; Parkkinen L; Darwent L; Hernandez D; Ansorge O; Clark LN; Honig LS; Marder K; Lemstra A; Scheltens P; van der Flier W; Louwersheimer E; Holstege H; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Clarimon J; Lleó A; Morenas-Rodríguez E; Lesage S; Galasko D; Masliah E; Santana I; Diez M; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Stone DJ; Pickering-Brown S; Mann D; Dickson DW; Halliday GM; Singleton A; Guerreiro R; Bras J
Article: CLINICAL INTERVENTIONS IN AGING. 2017;12:1215-1222
Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson's disease dementia.
Larsson V; Torisson G; Bülow M; Londos E
Article: BMC NEUROLOGY. 2016;16(1):156
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.
Wattmo C; Londos E; Minthon L
Article: JOURNAL OF ALZHEIMERS DISEASE. 2016;54(1):287-295
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Van Steenoven I; Aarsland D; Weintraub D; Londos E; Blanc 'E; Van der Flier WM; Teunissen CE; Mollenhaueri B; Fladby T; Kramberger MG; Bonanni L; Lemstra AW
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2016;17(8):706-711
Prevalence of Dementia With Lewy Body Symptoms: A Cross-Sectional Study in 40 Swedish Nursing Homes.
Zahirovic I; Wattmo C; Torisson G; Minthon L; Londos E
Article: MOVEMENT DISORDERS. 2016;31(8):1203-1208
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2016;14:90
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients.
Torisson G; Stavenow L; Minthon L; Londos E
Article: JOURNAL OF PARKINSONS DISEASE. 2016;6(1):99-108
Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
Article: NEUROBIOLOGY OF AGING. 2016;38:214.e7-214.e10
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
Guerreiro R; Escott-Price V; Darwent L; Parkkinen L; Ansorge O; Hernandez DG; Nalls MA; Clark L; Honig L; Marder K; van der Flier W; Holstege H; Louwersheimer E; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns NJ; Halliday GM; Mann D; Pickering-Brown S; Powell J; Lunnon K; Lupton MK; International Parkinson's Disease Genomics Consort; Dickson D; Hardy J; Singleton A; Bras J
Article: NEUROLOGY. 2015;85(21):1834-1842
Increased CSF biomarkers of angiogenesis in Parkinson disease.
Janelidze S; Lindqvist D; Francardo V; Hall S; Zetterberg H; Blennow K; Adler CH; Beach TG; Serrano GE; van Westen D; Londos E; Cenci MA; Hansson O
Article: ALZHEIMERS RESEARCH & THERAPY. 2015;7(1):63
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
Wennström M; Hall S; Nägga K; Londos E; Minthon L; Hansson O
Article: BMC GERIATRICS. 2015;15:65
Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.
Torisson G; van Westen D; Stavenow L; Minthon L; Londos E
Article: DIAGNOSTICS. 2015;5(2):113-118
A Diagnostic Model for Dementia in Clinical Practice-Case Methodology Assisting Dementia Diagnosis.
Londos E
Article: CLINICAL AUTONOMIC RESEARCH. 2015;25(2):87-94
Lack of orthostatic symptoms in dementia patients with orthostatic hypotension.
Bengtsson-Lindberg M; Larsson V; Minthon L; Wattmo C; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2015;40(5-6):297-310
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
Wattmo C; Londos E; Minthon L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2015;30(1):46-54
Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
Wesnes KA; Aarsland D; Ballard C; Londos E
Article: HUMAN MOLECULAR GENETICS. 2014;23(23):6139-6146
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.
Bras J; Guerreiro R; Darwent L; Parkkinen L; Ansorge O; Escott-Price V; Hernandez DG; Nalls MA; Clark LN; Honig LS; Marder K; Van Der Flier WM; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns N; Halliday GM; Mann D; Pickering-Brown S; Dickson DW; Singleton A; Hardy J
Article: BMC NEUROLOGY. 2014;14:173
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
Wattmo C; Londos E; Minthon L
Article: BMJ OPEN. 2014;4(7):e005158
Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
Stubendorff K; Larsson V; Ballard C; Minthon L; Aarsland D; Londos E
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2014;22(6):580-586
Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias
Creese B; Ballard C; Aarsland D; Londos E; Sharp S; Jones E
Article: JOURNAL OF ALZHEIMERS DISEASE. 2014;40(2):343-350
Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.
Nielsen HM; Hall S; Surova Y; Nägga K; Nilsson C; Londos E; Minthon L; Hansson O; Wennström M
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2014;38(5-6):286-299
Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up.
Wattmo C; Londos E; Minthon L
Article: ALZHEIMERS RESEARCH & THERAPY. 2014;6(3):25
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
Hansson O; Hall S; Ohrfelt A; Zetterberg H; Blennow K; Minthon L; Nägga K; Londos E; Varghese S; Majbour NK; Al-Hayani A; El-Agnaf OM
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2014;7:1-7
Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.
Wennström M; Nielsen HM; Orhan F; Londos E; Minthon L; Erhardt S
Article: CLINICAL INTERVENTIONS IN AGING. 2014;9:1951-1962
Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
Wattmo C; Londos E; Minthon L
Article: BMC NEUROLOGY. 2013;13:140
Dysphagia in Lewy body dementia - a clinical observational study of swallowing function by videofluoroscopic examination.
Londos E; Hanxsson O; Alm Hirsch I; Janneskog A; Bülow M; Palmqvist S
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2013;28(7):738-744
Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies.
Brunnström H; Hansson O; Zetterberg H; Londos E; Englund E
Article: CLINICAL INTERVENTIONS IN AGING. 2013;8:329-339
A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.
Wattmo C; Paulsson E; Minthon L; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2013;36(1-2):99-110
Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.
Nutu M; Zetterberg H; Londos E; Minthon L; Nägga K; Blennow K; Hansson O; Ohrfelt A
Article: CLINICAL INTERVENTIONS IN AGING. 2013;8:1295-1304
Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study.
Torisson G; Minthon L; Stavenow L; Londos E
Article: NEUROSCIENCE LETTERS. 2012;531(1):1-4
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias
Creese B; Ballard C; Aarsland D; Londos E; Sharp S; Jones E
Article: ARCHIVES OF NEUROLOGY. 2012;69(11):1445-1452
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Article: BMC GERIATRICS. 2012;12:47
Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals.
Torisson G; Minthon L; Stavenow L; Londos E
Article: JOURNAL OF ALZHEIMERS DISEASE. 2012;29(1):125-132
Altered CSF orexin and α-synuclein levels in dementia patients.
Wennström M; Londos E; Minthon L; Nielsen HM
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2012;32(2):114-119
A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values.
Hägerström D; Jakobsson D; Stomrud E; Andersson A-M; Ryding E; Londos E; Minthon L; Rosén I; Edenbrandt L
Article: CURRENT ALZHEIMER RESEARCH. 2012;9(3):257-266
Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
Nielsen HM; Palmqvist S; Minthon L; Londos E; Wennström M
Article: PLOS ONE. 2012;7(6):e38639
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
Palmqvist S; Hertze J; Minthon L; Wattmo C; Zetterberg H; Blennow K; Londos E; Hansson O
Article: PLOS ONE. 2012;7(10):e45451
The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
Stubendorff K; Aarsland D; Minthon L; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2012;33(2-3):156-163
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly
Stomrud E; Forsberg A; Hagerstrom D; Ryding E; Blennow K; Zetterberg H; Minthon L; Hansson O; Londos E
Article: ALZHEIMERS RESEARCH & THERAPY. 2011;3(4):23
Predictors of long-term cognitive outcome in Alzheimer's disease.
Wattmo C; Wallin AK; Londos E; Minthon L
Article: JOURNAL OF NEURAL TRANSMISSION. 2011;118(6):957-962
Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.
Gerhardsson L; Lundh T; Londos E; Minthon L
Article: GERONTOLOGIST. 2011;51(1):17-27
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
Wattmo C; Wallin AK; Londos E; Minthon L
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2011;82(2):160-164
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Mulugeta E; Londos E; Ballard C; Alves G; Zetterberg H; Blennow K; Skogseth R; Minthon L; Aarsland D
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2011;26(2):206-213
Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment
Johansson C; Ballard C; Hansson O; Palmqvist S; Minthon L; Aarsland D; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2011;32(6):408-416
Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer's disease--measured from a fixed cognitive level.
Stubendorff K; Hansson O; Minthon L; Londos E
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2011;25(1):63-72
Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.
Wattmo C; Wallin ÅK; Londos E; Minthon L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2011;26(1):100-105
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.
Andersson M; Zetterberg H; Minthon L; Blennow K; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2011;32(4):227-234
Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson's Disease Dementia
Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
Article: ALZHEIMERS RESEARCH & THERAPY. 2010;2(5):29
A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease.
Palmqvist S; Minthon L; Wattmo C; Londos E; Hansson O
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010;25(10):1030-1038
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia
Larsson V; Aarsland D; Ballard C; Minthon L; Londos E
Article: NEUROLOGY. 2010;74(19):1531-1537
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
Wallin AK; Blennow K; Zetterberg H; Londos E; Minthon L; Hansson O
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010;25(4):403-410
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
Sämgård K; Zetterberg H; Blennow K; Hansson O; Minthon L; Londos E
Article: NEUROBIOLOGY OF AGING. 2010;31(3):357-367
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Article: INTERNATIONAL PSYCHOGERIATRICS. 2010;22(2):321-327
α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies
Ballard C; Jones EL; Londos E; Minthon L; Francis P; Aarsland D
Article: ARCHIVES OF NEUROLOGY. 2010;67(2):217-223
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
Stomrud E; Hansson O; Zetterberg H; Blennow K; Minthon L; Londos E
Article: NEUROBIOLOGY OF AGING. 2010;31(2):215-223
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.
Stomrud E; Hansson O; Minthon L; Blennow K; Rosén I; Londos E
Article: EUROPEAN NEUROLOGY. 2010;63(6):326-330
Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients.
Zetterberg H; Tullhög K; Hansson O; Minthon L; Londos E; Blennow K
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2009;24(12):1405-1412
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests.
Palmqvist S; Hansson O; Minthon L; Londos E
Article: NEUROBIOLOGY OF AGING. 2009;30(8):1265-1271
CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.
Boström F; Hansson O; Gerhardsson L; Lundh T; Minthon L; Stomrud E; Zetterberg H; Londos E
Article: PLOS ONE. 2009;4(7):e6294
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
Buchhave P; Blennow K; Zetterberg H; Stomrud E; Londos E; Andreasen N; Minthon L; Hansson O
Article: LANCET NEUROLOGY. 2009;8(7):613-618
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
Article: ACTA RADIOLOGICA. 2009;50(6):674-681
Medial Temporal Lobe Atrophy Increases the Specificity of Cerebrospinal Fluid Biomarkers in Alzheimer Disease with Minor Cerebrovascular Changes
Zhang Y; Londos E; Minthon L; Wattmo C; Blennow K; Liu HJ; Bronge L; Aspelin P; Wahlund L-O
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2009;24(6):638-647
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
Wallin AK; Hansson O; Blennow K; Londos E; Minthon L
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2009;28(1):88-94
Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Blennow K; Lundh T; Londos E; Minthon L
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2009;28(4):314-319
Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.
Boström F; Hansson O; Blennow K; Gerhardsson L; Lundh T; Minthon L; Zetterberg H; Londos E
Article: AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS. 2008;23(5):439-446
The usefulness of cube copying for evaluating treatment of Alzheimer's disease.
Palmqvist S; Hansson O; Minthon L; Londos E
Article: ARCHIVES OF NEUROLOGY. 2008;65(8):1102-1107
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
Article: MOLECULAR IMMUNOLOGY. 2008;45(13):3649-3660
C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;67(6):626-631
Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Bodil Roth E; Theander E; Londos E; Sandberg-Wollheim M; Larsson A; Sjöberg K; Stenberg P
Article: AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS. 2008;23(2):177-183
Effects of a goal-oriented rehabilitation program in mild cognitive impairment: a pilot study.
Londos E; Boschian K; Lindén A; Persson C; Minthon L; Lexell J
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2008;23(2):192-198
The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies.
Andersson M; Hansson O; Minthon L; Ballard CG; Londos E
Article: ACTA RADIOLOGICA. 2008;49(1):91-97
Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease
Zhang Y; Londos E; Minthon L; Wattmo C; Liu H; Aspelin P; Wahlund L-O
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008;25(6):508-515
Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Lundh T; Minthon L; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008;26(3):284-290
Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.
Andersson M; Hansson O; Minthon L; Rosén I; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008;26(3):203-211
Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
Article: NEURODEGENERATIVE DISEASES. 2008;5(5):268-276
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Article: NEUROLOGY. 2007;69(16):1569-1579
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.
Nielsen HM; Minthon L; Londos E; Blennow K; Miranda E; Perez J; Crowther DC; Lomas DA; Janciauskiene SM
Article: AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS. 2007;22(4):313-318
A Quick Test for Cognitive Speed: a measure of cognitive speed in dementia with Lewy bodies.
Andersson M; Wiig EH; Minthon L; Londos E
Article: NEUROBIOLOGY OF DISEASE. 2007;26(1):27-35
Soluble adhesion molecules and angiotensin-converting enzyme in dementia.
Nielsen HM; Londos E; Minthon L; Janciauskiene SM
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007;21(2):150-154
Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease
Bostrom F; Jonsson L; Minthon L; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007;24(2):118-124
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.
Stomrud E; Hansson O; Blennow K; Minthon L; Londos E
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007;23(5):316-320
Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007;23(3):150-160
Donepezil in Alzheimer's disease:: What to expect after 3 years of treatment in a routine clinical setting
Wallin AK; Andreasen N; Eriksson S; Batsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Ryden M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Jonhagen ME; Minthon L
Article: LANCET NEUROLOGY. 2006;5(3):228-234
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2003;36(3):231-245
Regional cerebral blood flow and EEG in clinically diagnosed dementia with Lewy bodies and Alzheimer's disease.
Londos E; Passant U; Brun A; Rosén I; Risberg J; Gustafson L
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2002;13(3):130-148
Contributions of other brain pathologies in dementia with lewy bodies.
Londos E; Passant U; Risberg J; Gustafson L; Brun A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2001;16(7):667-679
Neuropathological correlates to clinically defined dementia with Lewy bodies.
Londos E; Passant U; Gustafson L; Brun A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2000;15(1):40-49
Clinical Lewy body dementia and the impact of vascular components.
Londos E; Passant U; Brun A; Gustafson L
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2000;30(1):35-46
Blood pressure and drug treatment in clinically diagnosed Lewy body dementia and Alzheimer's disease.
Londos E; Passant U; Gustafson L
Visa fler

Alla övriga publikationer

Corrigendum: SCIENTIFIC REPORTS. 2019;9(1):15168
Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.
Rongve A; Witoelar A; Ruiz A; Athanasiu L; Abdelnour C; Clarimon J; Heilmann-Heimbach S; Hernández I; Moreno-Grau S; de Rojas I; Morenas-Rodríguez E; Fladby T; Sando SB; Bråthen G; Blanc F; Bousiges O; Lemstra AW; van Steenoven I; Londos E; Almdahl IS; Pålhaugen L; Eriksen JA; Djurovic S; Stordal E; Saltvedt I; Ulstein ID; Bettella F; Desikan RS; Idland A-V; Toft M; Pihlstrøm L; Snaedal J; Tárraga L; Boada M; Lleó A; Stefánsson H; Stefánsson K; Ramírez A; Aarsland D; Andreassen OA
Letter: NEUROLOGY AND THERAPY. 2018;7(1):165-167
Author's Response to the Letter to the Editor Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives.
Londos E
Editorial comment: NEUROLOGY AND THERAPY. 2018;7(1):13-22
Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives.
Londos E
Corrigendum: NEUROSCIENCE LETTERS. 2014;580:178
No association of COMT vanl 158met polymorphism and psychotic symptoms in Lewy body dementias (vol 531, pg 1, 2014)
Creese B; Ballard C; Aarsland D; Londos E; Sharp S; Jones E
Published conference paper: NEURODEGENERATIVE DISEASES. 2012;10(1-4):229-231
A Pilot Study Examining Associations between DYRK1A and α-Synuclein Dementias
Jones EL; Aarsland D; Londos E; Ballard C
Review: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(8):713-719
Patients with Lewy body dementia use more resources than those with Alzheimer's disease
Bostrom F; Jonsson L; Minthon L; Londos E
Review: NEUROLOGY. 2005;65(12):1863-1872
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
McKeith IG; Dickson DW; Lowe J; Emre M; O'Brien JT; Feldman H; Cummings J; Duda JE; Lippa C; Perry EK; Aarsland D; Arai H; Ballard CG; Boeve B; Burn DJ; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz CG; Gomez-Tortosa E; Halliday G; Hansen LA; Hardy J; Iwatsubo T; Kalaria RN; Kaufer D; Kenny RA; Korczyn A; Kosaka K; Lee VMY; Lees A; Litvan I; Londos E; Lopez OL; Minoshima S; Mizuno Y; Molina JA; Mukaetova-Ladinska EB; Pasquier F; Perry RH; Schulz JB; Trojanowski JQ; Yamada M

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI